12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·06/05/2024 12:06:43

Listen to the news

Gainers

ENDRA Life Sciences (NASDAQ:NDRA) stock increased by 71.6% to $0.15 during Wednesday's pre-market session. The company's market cap stands at $1.5 million.
Concord Medical Services (NYSE:CCM) stock moved upwards by 29.04% to $2.71. The company's market cap stands at $117.6 million.
Barinthus Biotherapeutics (NASDAQ:BRNS) shares increased by 21.69% to $2.3. The market value of their outstanding shares is at $89.7 million.
Heart Test Laboratories (NASDAQ:HSCS) stock moved upwards by 12.87% to $5.81. The company's market cap stands at $3.8 million.
I-MAB (NASDAQ:IMAB) shares increased by 12.23% to $2.11. The company's market cap stands at $170.6 million.
Agenus (NASDAQ:AGEN) stock rose 11.54% to $19.52. The company's market cap stands at $409.9 million.

Losers

SILO Pharma (NASDAQ:SILO) shares declined by 34.7% to $1.47 during Wednesday's pre-market session. The company's market cap stands at $4.1 million.
Cue Health (NASDAQ:HLTH) stock decreased by 25.57% to $0.05. The company's market cap stands at $7.3 million.
Fresh2 Group (NASDAQ:FRES) stock decreased by 20.52% to $0.35. The market value of their outstanding shares is at $8.6 million.
ThermoGenesis Holdings (NASDAQ:THMO) stock fell 13.31% to $0.55. The market value of their outstanding shares is at $4.4 million.
Compass Pathways (NASDAQ:CMPS) shares decreased by 13.3% to $6.65. The company's market cap stands at $454.7 million.
Marker Therapeutics (NASDAQ:MRKR) stock fell 12.09% to $3.2. The market value of their outstanding shares is at $28.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English